Search research articles
Contact Us
Filters
Showing results (71-80 of 157) with videos related to
Page
of 16
Sort By:
Cancer
|
July 15, 1996
Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges
J J Lokich, C L Moore, N R Anderson
Oncology
|
January 1, 1975
Combined 5-fluorouracil and hydroxyurea therapy for gastrointestinal cancer
J J Lokich, S W Pitman, A T Skarin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1985
A pilot study of protracted venous infusion of 5-fluorouracil and concomitant radiation therapy
T A Rich, J J Lokich, J T Chaffey
Cancer
|
July 15, 1996
Comparison of costs for infusion versus bolus chemotherapy administration--Part two. Use of charges versus reimbursement for cost basis
J J Lokich, C L Moore, N R Anderson
Cancer Treatment Reports
|
September 1, 1983
Phase I study of continuous venous infusion of floxuridine (5-FUDR) chemotherapy
J J Lokich, H Sonneborn, S Paul, et al.
Cancer
|
August 1, 1976
New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease
J J Lokich, E Frei, N Jaffe, et al.
Cancer Treatment Reports
|
September 1, 1982
Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report
H W Bruckner, J J Lokich, D M Stablein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1985
Complications and management of implanted venous access catheters
J J Lokich, A Bothe, P Benotti, et al.
Cancer
|
December 15, 1981
Concomitant hepatic radiation and intraarterial fluorinated pyrimidine therapy: correlation of liver scan, liver function tests, and plasma CEA with tumor response
J Lokich, T Kinsella, J Perri, et al.
Cancer Investigation
|
December 11, 1999
A dose-escalation phase II clinical trial of infusional mitomycin C for 7 days in patients with advanced measurable colorectal cancer refractory or resistant to 5-fluorouracil
N Anderson, J Lokich, C Moore, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 157) with videos related to
Sort By:
Page
of 16
Cancer
|
July 15, 1996
Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges
J J Lokich, C L Moore, N R Anderson
Oncology
|
January 1, 1975
Combined 5-fluorouracil and hydroxyurea therapy for gastrointestinal cancer
J J Lokich, S W Pitman, A T Skarin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 1985
A pilot study of protracted venous infusion of 5-fluorouracil and concomitant radiation therapy
T A Rich, J J Lokich, J T Chaffey
Cancer
|
July 15, 1996
Comparison of costs for infusion versus bolus chemotherapy administration--Part two. Use of charges versus reimbursement for cost basis
J J Lokich, C L Moore, N R Anderson
Cancer Treatment Reports
|
September 1, 1983
Phase I study of continuous venous infusion of floxuridine (5-FUDR) chemotherapy
J J Lokich, H Sonneborn, S Paul, et al.
Cancer
|
August 1, 1976
New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease
J J Lokich, E Frei, N Jaffe, et al.
Cancer Treatment Reports
|
September 1, 1982
Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report
H W Bruckner, J J Lokich, D M Stablein
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1985
Complications and management of implanted venous access catheters
J J Lokich, A Bothe, P Benotti, et al.
Cancer
|
December 15, 1981
Concomitant hepatic radiation and intraarterial fluorinated pyrimidine therapy: correlation of liver scan, liver function tests, and plasma CEA with tumor response
J Lokich, T Kinsella, J Perri, et al.
Cancer Investigation
|
December 11, 1999
A dose-escalation phase II clinical trial of infusional mitomycin C for 7 days in patients with advanced measurable colorectal cancer refractory or resistant to 5-fluorouracil
N Anderson, J Lokich, C Moore, et al.
Page
of 16